Investigation Progression on the Relationship between Adiponectin and Insulin Resistance
Yongning Sun
Abstract
Yongning Sun
Abstract
Adiponectin is one of the novel adipocytokines participates in the development of insulin resistance which is the common pathological basis of Type 2 Diabetes Mellitus and Metabolic Syndrome.Numerous studies have demonstrated that adiponectin is significantly correlated with the development of insulin resistance.It can ameliorate insulin sensitivity,improves glucose and lipid metabolism in vivo.The levels of adiponectin in vivo could predict the development of insulin resistance.Simultaneously,various of methods could ameliorate insulin resistance by increasing the levels of adiponectin in vivo in Traditional Chinese Medicine.Discovery of adiponectin provides a new idea for the theoretical studies and clinical preventions to insulin resistance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Adiponectin is one of the novel adipocytokines participates in the development of insulin resistance which is the common pathological basis of Type 2 Diabetes Mellitus and Metabolic Syndrome.Numerous studies have demonstrated that adiponectin is significantly correlated with the development of insulin resistance.It can ameliorate insulin sensitivity,improves glucose and lipid metabolism in vivo.The levels of adiponectin in vivo could predict the development of insulin resistance.Simultaneously,various of methods could ameliorate insulin resistance by increasing the levels of adiponectin in vivo in Traditional Chinese Medicine.Discovery of adiponectin provides a new idea for the theoretical studies and clinical preventions to insulin resistance.
Key concepts: Adiponectin, Insulin resistance, Medicine, Adipokine, In vivo, Internal medicine, Insulin, Type 2 Diabetes Mellitus